Table 13.6b

Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006

Recipients with Heart-Lung Transplants

  Discharge Regimen (w/ or w/o Steroids Use) All
CyA Tac CyA+ MMF Tac+ MMF CyA+ Aza Tac+ Aza Tac+ Siro Other
Functioning Graft with Immunosuppression Info at Discharge 2 10 19 44 28 17 1 6 127
% of All Regimens 1.6% 7.9% 15.0% 34.6% 22.0% 13.4% 0.8% 4.7% 100.0%
Induction Drug 0.0% 0.0% 5.3% 4.5% 32.1% 0.0% 0.0% 66.7% 12.6%
Atgam/NRATG/NRATS
OKT3 0.0% 0.0% 5.3% 2.3% 10.7% 0.0% 0.0% 0.0% 3.9%
Thymoglobulin 0.0% 0.0% 0.0% 15.9% 0.0% 11.8% 100.0% 33.3% 9.4%
Zenapax 0.0% 0.0% 21.1% 13.6% 14.3% 29.4% 0.0% 66.7% 18.1%
Simulect 0.0% 0.0% 42.1% 9.1% 10.7% 23.5% 0.0% 116.7% 20.5%
Campath 0.0% 10.0% 0.0% 20.5% 0.0% 0.0% 0.0% 33.3% 9.4%
No Induction Drugs Recorded 100.0% 90.0% 31.6% 34.1% 35.7% 35.3% 0.0% 0.0% 37.8%


Source: OPTN/SRTR Data as of May 1, 2007.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.